Apr 26 |
Looking Into Ascendis Pharma's Recent Short Interest
|
Apr 25 |
Ascendis Pharma to Report First Quarter 2024 Financial Results and Provide Business Update on May 2, 2024
|
Apr 24 |
United Kingdom’s MHRA Approves YORVIPATH® (palopegteriparatide) in Great Britain for the Treatment of Adults with Chronic Hypoparathyroidism
|
Apr 3 |
Here's How Much You Would Have Made Owning Ascendis Pharma Stock In The Last 10 Years
|
Apr 2 |
Biotech With 520% Sales Growth Nears Next Buy Point
|
Mar 22 |
Two Health Care Stocks Outperform S&P 500, Offer Entries
|
Mar 22 |
Are Medical Stocks Lagging AdaptHealth (AHCO) This Year?
|
Mar 22 |
Argenx (ARGX) Moves 11.2% Higher: Will This Strength Last?
|
Mar 22 |
Ascendis Pharma A/S (ASND) Rose on Positive Trial Results
|
Mar 17 |
30 Biggest Biotechnology Companies in the World
|